Want to see HK:3320 full AI Analyst Report?
China Resources Pharmaceutical Group Ltd. (3320) Revenue
China Resources Pharmaceutical Group Ltd. Revenue
China Resources Pharmaceutical Group Ltd. had a revenue of 153.28B in the quarter ending Jun 30, 2026, with 0.01%. This bring the company's revenue in the last twelve months to 306.54B, Increased 2.95%. In the fiscal year ending Dec 31, 2025, China Resources Pharmaceutical Group Ltd. had annual revenue of 300.01B with 9.42% growth.
- Revenue (ttm)
- 306.54B
- Revenue Growth
- 7.94%
- P/S Ratio
- 0.10
- Revenue/Employee
- HKD 3,571,584
- Employees
- 84,000
- Market Cap
- HKD 29.12B
Revenue Chart
China Resources Pharmaceutical Group Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 300.01B | 25.83B | 9.42% |
| Dec 31, 2024 | 274.18B | 3.79B | 1.40% |
| Dec 31, 2023 | 270.40B | 47.27B | 21.18% |
| Dec 31, 2022 | 223.13B | 29.89B | 15.47% |
| Dec 31, 2021 | 193.24B | 24.61B | 14.59% |
| Dec 31, 2020 | 168.63B | -11.46B | -6.36% |
| Dec 31, 2019 | 180.08B | 21.34B | 13.44% |
| Dec 31, 2018 | 158.75B | 13.19B | 9.06% |
| Dec 31, 2017 | 145.55B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.